Wallace Advisory Group, LLC Bristol Myers Squibb CO Transaction History
Wallace Advisory Group, LLC
- $137 Billion
- Q3 2024
A detailed history of Wallace Advisory Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wallace Advisory Group, LLC holds 6,444 shares of BMY stock, worth $373,752. This represents 0.2% of its overall portfolio holdings.
Number of Shares
6,444
Previous 6,646
3.04%
Holding current value
$373,752
Previous $276 Million
3.04%
% of portfolio
0.2%
Previous 0.2%
Shares
7 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.9 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.2 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.39 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.52 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.54 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $123B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...